MicroRNA-101-3p advances cisplatin sensitivity in bladder urothelial carcinoma through targeted silencing EZH2

Conclusion: The expression of miR-101-3p is positively related to CDDP sensitivity of BUC, miR-101-3p advances sensitivity of BUC to CDDP through targeted silencing EZH2.

Source: Journal of Cancer - June 13, 2019 Category: Cancer & Oncology Authors: Bo Li, Dalong Xie, Hui Zhang Tags: Research Paper Source Type: research